1,648.73p-10.67 (-0.64%)09 Aug 2022, 08:36
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Gsk PLC Fundamentals

Company NameGsk PLCLast Updated2022-08-09
IndustryDrug Manufacturers - GeneralSectorHealthcare
Shares in Issue4.067 bnMarket Cap£67.02 bn
PE Ratio14.60Dividend per Share£1.00
Dividend Yield5.65Dividend Cover1.08
EPS£1.08EPS Growth (%)0.12
PEG1.75DPS Growth (%)0
Debt Ratio0.2483Debt Equity Ratio1.1472
Asset Equity Ratio3.9331Cash Equity Ratio0.2885
Quick Ratio0.3433Current Ratio1.43
Price To Book Value4.1220ROCE0

Gsk PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Gsk PLC Company Financials

Tangible Assets£10.67 bn£11.01 bn£11.31 bn
Intangible Assets£40.63 bn£40.42 bn£41.52 bn
Investments£2.21 bn£3.42 bn£2.15 bn
Total Fixed Assets£60.43 bn£60.18 bn£60.20 bn
Stocks£5.78 bn£6.00 bn£5.95 bn
Debtors£7.54 bn£6.59 bn£6.89 bn
Cash & Equivalents£4.13 bn£6.17 bn£4.59 bn
Other Assets£6.91 bn£5.33 bn£5.22 bn
Total Assets£79.10 bn£80.43 bn£79.69 bn
Creditors within 1 year£23.67 bn£22.15 bn£24.05 bn
Creditors after 1 year£34.09 bn£37.48 bn£37.28 bn
Other Liabilities000
Total Liabilities£57.76 bn£59.62 bn£61.34 bn
Net assets£21.34 bn£20.81 bn£18.36 bn
Called up share capital£1.35 bn£1.35 bn£1.35 bn
Share Premium£3.30 bn£3.28 bn£3.17 bn
Profit / Loss£5.44 bn£6.97 bn£6.22 bn
Other Equity£15.05 bn£14.59 bn£11.40 bn
Preference & Minorities£6.29 bn£6.22 bn£6.95 bn
Total Capital Employed£21.34 bn£20.81 bn£18.36 bn
Debt Ratio£0.58£0.62£0.67
Assets / Equity3.93313.93313.9331
Cash / Equity0.28850.28850.2885
Cash Flow202120202019
Cash from operating activities£7.95 bn£8.44 bn£8.02 bn
Cashflow before financing£363.00 m-£1.69 bn£6.18 bn
Increase in Cash-£1.41 bn£470.00 m£826.00 m
Turnover£34.11 bn£34.10 bn£33.75 bn
Cost of sales£11.60 bn£11.70 bn£11.86 bn
Gross Profit£22.51 bn£22.39 bn£21.89 bn
Operating Profit£6.20 bn£7.78 bn£6.96 bn
Pre-Tax profit£5.44 bn£6.97 bn£6.22 bn

Gsk PLC Company Background

ActivitiesIn the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Latest Interim Date27 Jul 2022
Latest Fiscal Year End Date9 Feb 2022

Gsk PLC Directors

2017-03-14Sir Deryck MaughanNon-Executive Director
2009-04-01Sir Ian Maurice Gray ProsserNon-Executive Director
2012-04-02Mr. James R. MurdochNon-Executive Director
2011-08-09Dr. Jean-Pierre GarnierExecutive Director,Chief Executive Officer
2021-04-28Ms. Lynn Laverty ElsenhansNon-Executive Director
2017-03-14Dr. Stephanie A. BurnsNon-Executive Director
2021-07-26Dr. Hal V Barron Executive Director,Chief Scientific Officer and President, RandD
2021-04-28Ms. Judy C. LewentNon-Executive Director
2021-04-28Dr. Laurie H. Glimcher, M.D.Non-Executive Director
2015-05-07Sir Christopher Charles GentNon-Executive Director,Chairman
2018-03-13Sir Andrew P. WittyExecutive Director,Chief Executive Officer
2008-08-04Mr. Chris ViehbacherExecutive Director
2013-05-03Sir Crispin H. DavisNon-Executive Director
2017-03-14Dr. Daniel Podolsky, JrNon-Executive Director
2017-03-14Mr. Gerardus Johannes Wijers Non-Executive Director
2021-04-28Sir Jonathan Richard Symonds, CBENon-Executive Director,Chairman
2011-10-20Mr. Julian HeslopExecutive Director,Chief Financial Officer
2012-09-28Mr. Lawrence CulpNon-Executive Director
2021-04-28Mr. Manvinder Singh BangaNon-Executive Director,Senior Independent Director
2018-03-13Dr. Moncef M. Slaoui, PhDChairman, Global R&D and Vaccines
2021-03-09Sir Philip Roy Hampton KBNon-Executive Director,Chairman
2015-05-07Mr. Tom De SwaanNon-Executive Director
2021-04-28Mr. Urs RohnerNon-Executive Director
2021-04-28Dr. Vivienne Cox, CBENon-Executive Director
2014-07-23Sir Robert Peter WilsonNon-Executive Director
2018-05-04Professor Sir. Roy AndersonNon-Executive Director
2021-04-28Mr. Charles A. BancroftNon-Executive Director
2017-03-15Ms. Stacey CartwrightNon-Executive Director
2016-03-17Dr. Ronaldo Hermann SchmitzNon-Executive Director
2021-03-09Mrs. Victoria Anne WhyteCompany Secretary
2021-07-14Mr. Iain J MackayExecutive Director,Chief Financial Officer
2020-03-06Mr. Simon P Dingemans Executive Director,Chief Financial Officer
2018-03-28Mr. Patrick VallanceExecutive Director
2021-07-16Ms. Emma N. WalmsleyExecutive Director,Chief Executive Officer
2015-05-07Ms. Jing UlrichNon-Executive Director
2021-04-28Dr. Jesse GoodmanNon-Executive Director

Gsk PLC Contact Details

Company NameGSK PLC
Address980 Great West Road, Brentford, TW8 9GS
Telephone+44 2080475000

Gsk PLC Advisors

AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
Financial PR AdviserBrunswick Group LLP
Phone+44 2074045959
Fax+44 2078312823
SolicitorAllen & Overy LLP
Phone+44 2030880000
Fax+44 207339999
BankNational Westminster Bank PLC
RegistrarEquiniti Limited
Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
Phone+44 2079864000
Fax+44 2079862266
AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
SolicitorCleary Gottlieb Steen & Hamilton
Phone+1 212 225-2000
Fax+1 212 225-3999
AuditorCoopers & Lybrand